MONICA WRIGHT: Open Payments
NPI 1285007518 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,207 in 116 payments from 17 companies in 2025. Trend: 2023 $2,130 · 2024 $2,748 · 2025 $2,207
Food & beverage: $2,207
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $526 |
| Lilly USA, LLC | 21 | $304 |
| PFIZER INC. | 15 | $248 |
| AstraZeneca Pharmaceuticals LP | 9 | $216 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $192 |
| GlaxoSmithKline, LLC. | 7 | $120 |
| Exact Sciences Corporation | 6 | $101 |
| ABBVIE INC. | 4 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $78 |
| Astellas Pharma US Inc | 4 | $67 |
Products named: Ozempic, XIFAXAN, JARDIANCE, ELIQUIS, MOUNJARO, Wegovy, BREZTRI, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
